PROTEIN-LOSING GASTROENTEROPATHY side effect
What is PROTEIN-LOSING GASTROENTEROPATHY ?PROTEIN-LOSING GASTROENTEROPATHY : Prograf Side Effects Report #5678241-5
Physician from JAPAN reported PROGRAF problem on Mar 04, 2008. Male patient, 17 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: protein-losing gastroenteropathy, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE. Patient recovered.
PROTEIN-LOSING GASTROENTEROPATHY : Prandin Side Effects Report #5588083-7
PRANDIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Male patient, 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with PRANDIN. After drug was administered, patient experienced the following problems/side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis, . PRANDIN dosage: .5 MG, TID. During the same period patient was treated with TRIAMTERENE, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient died.
PROTEIN-LOSING GASTROENTEROPATHY : Prandin Side Effects Report #5379937-5
Consumer or non-health professional from UNITED STATES reported PRANDIN problem on June 25, 2007. Male patient, 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with PRANDIN. After drug was administered, patient experienced the following problems/side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis, . PRANDIN dosage: .5 MG, TID. During the same period patient was treated with TRIAMTERENE, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient died.
PROTEIN-LOSING GASTROENTEROPATHY : Prandin Side Effects Report #5379937-5
PRANDIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Male patient, 40 years of age, weighting 127.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with PRANDIN. After drug was administered, patient experienced the following problems/side effects: lymphangiectasia intestinal, protein-losing gastroenteropathy, sepsis, . PRANDIN dosage: .5 MG, TID. During the same period patient was treated with TRIAMTERENE, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient died.